Lenacapavir administered every 26 weeks or daily in combination with oral daily antiretroviral therapy for initial treatment of HIV: a randomised, open-label, active-controlled, phase 2 trial
Titel:
Lenacapavir administered every 26 weeks or daily in combination with oral daily antiretroviral therapy for initial treatment of HIV: a randomised, open-label, active-controlled, phase 2 trial
Auteur:
Gupta, Samir K Berhe, Mezgebe Crofoot, Gordon Benson, Paul Ramgopal, Moti Sims, James McDonald, Cheryl Ruane, Peter Sanchez, William E Scribner, Anita Liu, Shan-Yu VanderVeen, Laurie A Dvory-Sobol, Hadas Rhee, Martin S Baeten, Jared M Koenig, Ellen